Scientists debate CDC recommendations during meningitis outbreak

February 5, 2013

A pair of commentaries to appear in an upcoming issue of the journal Antimicrobial Agents and Chemotherapy highlight a debate within the public health community surrounding Centers for Disease Control and Prevention (CDC) recommendations for treatment of exposed individuals during last year's fungal meningitis outbreak. Manuscripts of the commentaries were published ahead of print today on the journal's webpage.

"I will try to offer sufficient documentation to show there are alternative approaches worthy of consideration," writes David A Stevens of Stanford University Medical School, the author of the first commentary which questions the .

In late 2012 the United States experienced its largest reported healthcare-associated outbreak when some patients who had received contaminated steroid shots developed . As of January 14, 2013 there have been 678 cases and 44 deaths reported. Approximately 14,000 people were potentially exposed to the contaminated steroids. During the outbreak the CDC recommended that clinicians closely monitor individuals who had been exposed but specifically recommended against the use of preventative (prophylactic) use of antifungal drugs in asymptomatic patients in the absence of a of meningitis infection.

In his commentary, Stevens puts forth a detailed argument concluding that the CDC should have recommended prophylactic treatment with oral for all exposed individuals. He also voiced other concerns with the CDC recommendations including the focus on only two specific drugs for treatment.

"If I were advising any patient who had been injected intrathecally or into a space adjacent to the intrathecal sac with material from one of the known contaminated lots, I would recommend taking chances with the known, uncommon and usually inconsequential side effects of the oral drugs…and try to prevent onset of a serious and ," writes Stevens.

In the second commentary, a rebuttal of the Stevens' commentary, a group of scientists including one CDC official defend the CDC's recommendation against prophylactic antifungal therapy, describing the CDC's decision analysis model.

"Most of these cases resulted from epidural injections; these patients did not intentionally receive intrathecal injections, as suggested by Stevens," write the scientists. "Clinicians must carefully weigh the benefit of treatment of asymptomatic patients with the significant expense associated with drug acquisition, monitoring drug levels and substantial drug-drug interactions. For this reason, CDC chose to recommend careful clinical evaluation and imaging for high risk patients, independent of symptoms, with the goal of finding early indications of infection."

The manuscripts of the commentaries are available online at and Formal publication is scheduled for the April 2013 issue of Antimicrobial Agents and Chemotherapy.

Explore further: US warns meningitis cases could rise

Related Stories

US warns meningitis cases could rise

October 12, 2012

US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

New insight on managing fungal meningitis

October 24, 2012

As the number of fungal meningitis cases continues to rise, physicians across the country are faced with how best to provide the early treatment that can save lives.

Fungal meningitis deaths rise to 24, CDC reports

October 25, 2012

The U.S. Centers for Disease Control and Prevention reported Wednesday that a 24th person had died of fungal meningitis after receiving contaminated steroid injections. The latest victim had received an injection to treat ...

Early clinical observations in the fungal meningitis outbreak

November 12, 2012

A new article being published early online in Annals of Internal Medicine describes the diagnosis and treatment protocol established in a Roanoke, Va. hospital to care for dozens of patients presenting with suspected fungal ...

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 07, 2013
CDC refused to admit that they knew the Darkfield Microscopy would have quickly, inexpensively, diagnosed all 14,000 potential victims with the specific type of fungus infection involved. With that knowledge specific treatment could have saved a lot of lives and lives in the future.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.